Angelique Nicolas Messi | Computational Chemistry | Best Researcher Award

Published on by Nano Technology

Dr. Angelique Nicolas Messi | Computational Chemistry | Best Researcher Award

Department of Organic Chemistry, University of Yaoundé 1 | Cameroon

Dr. Angelique Nicolas Messi is a distinguished Cameroonian organic chemist and Senior Lecturer at the Department of Organic Chemistry, University of Yaoundé I. He also serves as the Head of the Department of Basic and Applied Fundamental Sciences at the State University of Ebolowa, where he teaches general and organic chemistry, analytical chemistry, thermodynamics, pharmacognosy, and research methodology. Dr. Messi earned his Ph.D. in Organic Chemistry from the University of Yaoundé I in 2018, focusing on the isolation, structural elucidation, and bioassay of biflavonoids from Ochna species. He expanded his expertise as a Postdoctoral Research Fellow at the University of Fribourg in Switzerland under Prof. Christian G. Bochet (2020–2021) and through research visits to the University of Free State, South Africa (2015, 2023). His research centers on pharmaceutical and natural product chemistry, emphasizing drug discovery from natural sources, including biflavonoids, flavonoids, and synthetic analogs with neuroprotective, anticancer, antimalarial, and anti-HIV properties. A prolific researcher and mentor, Dr. Messi has authored numerous peer-reviewed articles in high-impact journals such as Pharmaceutics, Molecular Neurobiology, Chemistry Africa, and Biochemical Systematics and Ecology. His scientific impact is reflected in 122 citations, an h-index of 5, and an i10-index of 4. Renowned for his expertise in chromatographic and spectroscopic techniques such as NMR, LC-MS, and HRESIMS, he has contributed significantly to the discovery of novel bioactive compounds. In recognition of his outstanding contributions, he was honored as the “Best Researcher in Organic Chemistry” in 2025 by the Research Chemistry Awards. Fluent in both French and English, Dr. Messi is an invited speaker at international conferences, a reviewer for leading scientific journals, and a strong advocate for green chemistry and sustainable drug development in Africa.

Profile: Google Scholar | Scopus

Featured Publications

  • Ndongo, J. T., Issa, M. E., Messi, A. N., Ngo Mbing, J., Cuendet, M., & Pegnyemb, D. E. (2015). Cytotoxic flavonoids and other constituents from the stem bark of Ochna schweinfurthiana. Natural Product Research, 29(17), 1684–1687.

  • Messi, A. N., Ngo Mbing, J., Ndongo, J. T., Nyegue, M. A., Tchinda, A. T., Yemeda, F. L., & Pegnyemb, D. E. (2016). Phenolic compounds from the roots of Ochna schweinfurthiana and their antioxidant and antiplasmodial activities. Phytochemistry Letters, 17, 119–125.

  • Djova, S. V., Nyegue, M. A., Messi, A. N., Afagnigni, A. D., & Etoa, F. X. (2019). Phytochemical study of aqueous extract of Ochna schweinfurthiana F. Hoffm powder bark and evaluation of their anti-inflammatory, cytotoxic, and genotoxic activities. Evidence-Based Complementary and Alternative Medicine, 2019, 8908343.

  • Messi, A. N., Bonnet, S. L., Owona, B. A., Wilhelm, A., Kamto, E. L. D., Ndongo, J. T., & Pegnyemb, D. E. (2022). In vitro and in silico potential inhibitory effects of new biflavonoids from Ochna rhizomatosa on HIV-1 integrase and Plasmodium falciparum. Pharmaceutics, 14(8), 1701.

  • Owona, B. A., Mary, A., Messi, A. N., Ravichandran, K. A., Mbing, J. N., & Pegnyemb, E. (2025). Biflavonoid methylchamaejasmin and Khaya grandifoliola extract inhibit NLRP3 inflammasome in THP-1 cell model of neuroinflammation. Molecular Neurobiology, 62(2), 1605–1619.

Prof. THOMAS MAVROMOUSTAKOS | Computational Nanotechnology | Outstanding Scientist Award

Published on by Nano Technology

Prof. THOMAS MAVROMOUSTAKOS | Computational Nanotechnology | Outstanding Scientist Award

Prof. THOMAS MAVROMOUSTAKOS , National and Kapodistrian University of Athens , Greece

Dr. Thomas Mavromoustakos is a distinguished chemist renowned for his groundbreaking contributions to medicinal chemistry and spectroscopy. With a Bachelor’s degree from the Chemistry Department at NKUA and MSc/PhD in Medicinal Chemistry from the University of Connecticut, USA, he has focused his research on designing novel drugs targeting various diseases, employing a wide array of physical chemical methodologies. His expertise spans Solid State Nuclear Magnetic Resonance, High Resolution Nuclear Magnetic Resonance, X-ray diffraction, Raman Spectroscopy, and more. Dr. Mavromoustakos is also involved in authenticity studies of beverages and foods, utilizing advanced spectroscopic techniques. He has an extensive teaching experience, offering courses and labs in organic chemistry, molecular modeling, and NMR spectroscopy at various academic institutions

Professional Profile:

Google scholar

Orcid

Scopus

🎓 Education:

Dr. Thomas Mavromoustakos completed his Bachelor’s degree in Chemistry from NKUA in 1980, followed by pursuing an MSc in Medicinal Chemistry at the University of Connecticut, USA, in 1988. Continuing his academic journey, he attained a PhD in Medicinal Chemistry from the University of Connecticut, USA, in 1990. These educational milestones laid a solid foundation for his distinguished career in research and academia, enabling him to specialize in the design of novel drugs and contribute significantly to the fields of chemistry and pharmacology

🔬 Research Focus:

Dr. Mavromoustakos specializes in designing novel drugs for various diseases, employing physical chemical methodologies such as Solid State Nuclear Magnetic Resonance, High Resolution Nuclear Magnetic Resonance, Conformational Analysis, Differential Scanning Calorimetry, X-ray diffraction, Raman Spectroscopy, 3D-QSAR studies, and Docking studies.

👨‍🏫 Teaching Experience:

Dr. Mavromoustakos has taught numerous courses and laboratory sessions in various institutions, covering topics such as Molecular Modeling, Organic Chemistry, Polymers, Oenology, Food Chemistry, and Pharmacology.With his expertise and dedication, Dr. Mavromoustakos has made significant contributions to the fields of chemistry and pharmacology, shaping the future of drug design and analysis.

Publication top Notes: